>The plus for mnta is the fda refused to approve omnitrope as a true generic and I'd think it's MUCH closer to being an actual copy than any of the others trying with lovenox<
Because the Omnitrope application was a 505b2 rather than an ANDA, I don’t think the FDA had the option of declaring that Omnitrope was a full-fledged generic substitute for Genotropin. If the FDA had done that, PFE might have had a good lawsuit.
Market Data 
Markets 
AI
